You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

EXPLORE THE COMPASS GROUP

Compass Associates

Multi-award-winning recruitment consultancy dedicated to the independent Health, Social Care and Children's Services sectors.

Compass Executives

Dedicated Executive Search services for Health, Social Care, Children's Services & Education and Life Sciences. Covering the UK, International Investor, Advisory Services and Private Business sectors.

Compass Corporate Services

Recruitment solutions with full coverage of HR, Finance & Accounting, Marketing & Communications and Property & Estates for the independent Health and Social Care markets.

What impact will COP26 have on the Life Sciences Industry?

This November, the UK will be hosting COP26, a UN global event on tackling climate change. Our latest article looks at this year's COP26 theme of Health and Climate Action,...

News

Novartis’ Scemblix approved by the EC for adults with chronic myeloid leukaemia

It is estimated that every year more than 6,300 people will be diagnosed with CML in Europe

Novartis has announced that the European Commission (EC) has approved Scemblix – also known as asciminib – for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukaemia (CML) in chronic phase which has been previously treated with two or more tyrosine kinase inhibitors (TKIs).